EMA Product Specific GL [Regulatives / Guidelines]

posted by mmw – India, 2017-07-14 16:50 (2471 d 00:54 ago) – Posting: # 17548
Views: 9,457

Dear all,

EMA adopted a new batch of product specific guidances. Published on 10/07/2017:

Crizotinib
Elvitegravir / cobicistat / emtricitabine / te­no­fovir disoproxil
Elvitegravir
Emtricitabine, rilpivirine, tenofovir, disopro­xil
Vortioxetine

Thanks

MMW

Complete thread:

UA Flag
Activity
 Admin contact
22,988 posts in 4,825 threads, 1,661 registered users;
84 visitors (0 registered, 84 guests [including 6 identified bots]).
Forum time: 17:45 CEST (Europe/Vienna)

The only way to comprehend what mathematicians mean by Infinity
is to contemplate the extent of human stupidity.    Voltaire

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5